Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice

Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated with a progressive increase in risk of atherosclerosis and cardiovascular death. To prevent progression of both kidney fibrosis and atheroscler...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS One
Asıl Yazarlar: Bisgaard, Line S., Bosteen, Markus H., Fink, Lisbeth N., Sørensen, Charlotte M., Rosendahl, Alexander, Mogensen, Christina K., Rasmussen, Salka E., Rolin, Bidda, Nielsen, Lars B., Pedersen, Tanja X.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161477/
https://ncbi.nlm.nih.gov/pubmed/27992511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0168396
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller